Test Price
2,800 AED✅ Home Collection Available
FBLIM1 Gene (Kindler Syndrome) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين FBLIM1 لمتلازمة كيندلر في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: Hospital-Grade Home Collection with ISO-Certified Cold-Chain Transport and VIP Mobile Phlebotomy (8 AM – 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance with a Genetic Counselor to interpret results.
Insurance: Direct Billing Verification via WhatsApp
+971 54 548 8731.
الفحص الجيني المتقدم لجين FBLIM1 باستخدام التسلسل الجيني من الجيل التالي (NGS) لتشخيص متلازمة كيندلر بدقة تصل إلى 99.9% عبر مختبر معتمد من هيئة الصحة بدبي ومعيار ISO 9001:2015. يتضمن خدمة سحب الدم المنزلية المعتمدة والاستشارة الجينية الهاتفية بعد الفحص. نضمن خصوصية بياناتك بموجب قانون حماية البيانات الشخصية الإماراتي.
Test Overview: Clinical Precision Meets Patient-Centric Design
The FBLIM1 Next-Generation Sequencing (Genetic Test provides exhaustive analysis of the entire FBLIM1 gene, capturing single nucleotide variants, indels, and deep intronic mutations with >99.9% diagnostic sensitivity for Kindler syndrome—a rare dermato-osteo-immunological disorder.
This test is the definitive genetic tool for dermatologists, immunologists, and clinical geneticists, enabling accurate diagnosis, prognosis, and multidisciplinary care planning.
| Feature | Our NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) – full gene coverage | Targeted single-exon Sanger sequencing |
| Gene Coverage | 100% coding exons ± 10 bp flanking intronic regions | Limited to selected exons (typically <80% coverage) |
| Diagnostic Sensitivity | >99.9% | ~95% (misses deep intronic and copy-number variants) |
| Turnaround Time | 3 to 4 Weeks | 4 to 6 Weeks |
Consultant Dermatologist's Clinical Insight & Medication Safety
“As a DHA-licensed consultant dermatologist, I emphasize that this NGS test provides definitive molecular confirmation of Kindler syndrome, but the results must always be correlated with the clinical phenotype. A negative report does not exclude all atypical presentations or phenocopies; therefore, continued dermatological surveillance and multidisciplinary follow-up remain essential.”
— Dr. PRABHAKAR REDDY, DHA License No. 61713011
Medication Warning:
Do not discontinue any prescribed medication without consulting your treating physician. Genetic testing is diagnostic and does not substitute ongoing medical management.
⚠️ Exclusion Criteria & Emergency Red Flags
Exclusion Criteria
- Patients under 18 years of age without legal guardian consent and prior approval from the UAE Genetic Testing Committee (Federal Decree-Law No. 41 of 2024 & CDS Law 2026).
- Pregnant women, unless medically indicated after thorough genetic counseling.
- Active skin infection, cellulitis, or open wounds at the intended venipuncture site.
ER Red Flags (Seek Immediate Care)
- Rapidly enlarging, non-healing skin ulcer or lesion suspicious for squamous cell carcinoma.
- Signs of systemic infection (fever, chills) accompanied by severe blistering or skin fragility.
- Acute vision changes or eye pain (ectropion, keratitis).
Our service complies with UAE PDPL (Data Privacy), DHA regulations, and ISO 9001:2015 standards.
Patient FAQs & Clinical Guidance
What is the FBLIM1 Gene NGS Test?
The FBLIM1 Next-Generation Sequencing (NGS) Genetic Test is a high-precision diagnostic tool that detects mutations in the FBLIM1 gene causing Kindler syndrome, a rare inherited disorder characterized by skin fragility, photosensitivity, poikiloderma, and elevated risk of squamous cell carcinoma. This comprehensive gene analysis is essential to confirm the clinical diagnosis, guide surveillance protocols, and enable cascade testing in at‑risk family members.
الفحص الجيني للجين FBLIM1 باستخدام التسلسل الجيني من الجيل التالي هو أداة تشخيصية عالية الدقة للكشف عن الطفرات المسببة لمتلازمة كيندلر، وهو اضطراب وراثي نادر يتميز بهشاشة الجلد والحساسية للضوء وزيادة خطر الإصابة بسرطان الجلد، ويُعد ضرورياً لتأكيد التشخيص وتقديم المشورة الوراثية.
How is the sample collected and what is the turnaround time?
A simple blood sample, extracted DNA, or a dried blood spot on an FTA card is collected by our DHA-licensed phlebotomist during a home visit, with cold-chain transport ensuring DNA integrity. Turnaround time is 3 to 4 weeks from receipt of the specimen at our genomics facility.
يتم جمع عينة دم بسيطة أو حمض نووي مستخلص أو بقعة دم جافة على بطاقة FTA بواسطة أخصائي سحب دم مرخص من هيئة الصحة بدبي خلال زيارة منزلية، مع نقل مبرد لضمان سلامة العينة، وتظهر النتائج خلال 3 إلى 4 أسابيع.
Do I need a genetic counseling session before testing?
Pre- genetic counseling is required to review your family history, draw a pedigree, and ensure fully informed consent before sample collection. This mandatory session, provided by our certified genetic counselors, helps interpret the implications of a positive, negative, or variant-of-uncertain-significance result.
الاستشارة الوراثية قبل الفحص إلزامية لمراجعة تاريخك العائلي ورسم شجرة النسب والحصول على موافقة مستنيرة قبل سحب العينة. يقدمها مستشارونا الوراثيون المعتمدون لتفسير النتائج بدقة.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians